UPDATE: Sure enough the 100DMA was met with buying… for now…
The Nasdaq Biotech index is
down 4% from earlier opening highs and
is once again testing the 100-day-moving-average that provided some
impetus for a modest bounce yesterday. This is a 10-week low level (-14%
from Feb highs) and has
retraced over 60% of the gains since the Fed announced the taper in December. Volume has been very heavy.
READ MORE
Please share this article
No comments:
Post a Comment